총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Quest Diagnostics Incorporated (DGX), 포함 11 건 매수 및 33 건 매도. 내부자 매수 총액은 $27.15M 내부자 매도 총액은 $28.42M.
최근 활동이 있는 주요 내부자에는 Wentworth Timothy C, Prevoznik Michael E, Plewman Patrick. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — DGX
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-04-01 |
Wentworth Timothy C |
Director |
RSU 부여 |
198 |
- |
- |
198 |
| 2026-03-09 |
Wentworth Timothy C |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2026-03-09 |
Wentworth Timothy C |
Director |
RSU 부여 |
215 |
- |
- |
215 |
| 2026-03-05 |
Prevoznik Michael E |
SVP & General Counsel |
정보 매도 |
3,878 |
$206.21 |
$799.68K |
37,557 |
| 2026-03-05 |
Plewman Patrick |
SVP For Diagnostic Services |
정보 매도 |
2,855 |
$206.21 |
$588.73K |
15,198 |
| 2026-03-05 |
Doherty Catherine T. |
EVP, Regional Businesses |
정보 매도 |
5,558 |
$206.21 |
$1.15M |
67,122 |
| 2026-03-04 |
Prevoznik Michael E |
SVP & General Counsel |
RSU 원천징수 |
3,354 |
$204.86 |
$687.1K |
41,435 |
| 2026-03-04 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 원천징수 |
2,827 |
$204.86 |
$579.14K |
18,053 |
| 2026-03-04 |
Doherty Catherine T. |
EVP, Regional Businesses |
RSU 원천징수 |
5,806 |
$204.86 |
$1.19M |
72,680 |
| 2026-03-04 |
Davis J. E. |
CEO and President |
RSU 원천징수 |
26,414 |
$204.86 |
$5.41M |
142,423 |
| 2026-03-04 |
Samad Sam |
Executive Vice President & CFO |
RSU 원천징수 |
7,720 |
$204.86 |
$1.58M |
33,268 |
| 2026-03-04 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
RSU 원천징수 |
750 |
$204.86 |
$153.65K |
35,196 |
| 2026-03-04 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
정보 매도 |
2,628 |
$204.86 |
$538.37K |
13,441 |
| 2026-03-04 |
Delaney Mark E |
SVP & Chief Commercial Officer |
RSU 원천징수 |
2,326 |
$204.86 |
$476.5K |
11,864 |
| 2026-03-03 |
Prevoznik Michael E |
SVP & General Counsel |
정보 매도 |
526 |
$207.73 |
$109.27K |
37,557 |
| 2026-03-03 |
Plewman Patrick |
SVP For Diagnostic Services |
정보 매도 |
410 |
$207.73 |
$85.17K |
15,198 |
| 2026-03-03 |
Doherty Catherine T. |
EVP, Regional Businesses |
정보 매도 |
632 |
$207.73 |
$131.29K |
67,122 |
| 2026-03-02 |
Prevoznik Michael E |
SVP & General Counsel |
RSU 원천징수 |
288 |
$204.86 |
$59K |
38,083 |
| 2026-03-02 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 원천징수 |
230 |
$204.86 |
$47.12K |
15,608 |
| 2026-03-02 |
Doherty Catherine T. |
EVP, Regional Businesses |
RSU 원천징수 |
648 |
$204.86 |
$132.75K |
67,754 |
| 2026-03-02 |
Davis J. E. |
CEO and President |
정보 매도 |
10,000 |
$212.52 |
$2.13M |
117,185 |
| 2026-03-02 |
Samad Sam |
Executive Vice President & CFO |
RSU 원천징수 |
869 |
$204.86 |
$178.02K |
27,041 |
| 2026-03-02 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
RSU 원천징수 |
88 |
$204.86 |
$18.03K |
34,473 |
| 2026-03-02 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
RSU 원천징수 |
205 |
$204.86 |
$42K |
9,869 |
| 2026-03-02 |
Delaney Mark E |
SVP & Chief Commercial Officer |
RSU 원천징수 |
188 |
$204.86 |
$38.51K |
8,508 |
| 2026-02-19 |
Prevoznik Michael E |
SVP & General Counsel |
정보 매도 |
1,111 |
$204.83 |
$227.57K |
38,371 |
| 2026-02-19 |
Plewman Patrick |
SVP For Diagnostic Services |
정보 매도 |
958 |
$204.83 |
$196.23K |
15,838 |
| 2026-02-19 |
Doherty Catherine T. |
EVP, Regional Businesses |
정보 매도 |
1,433 |
$204.83 |
$293.52K |
68,402 |
| 2026-02-18 |
Prevoznik Michael E |
SVP & General Counsel |
RSU 부여 |
9,289 |
$204.96 |
$1.9M |
9,289 |
| 2026-02-18 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 부여 |
9,009 |
$204.96 |
$1.85M |
9,009 |
| 2026-02-18 |
Doherty Catherine T. |
EVP, Regional Businesses |
RSU 부여 |
13,514 |
$204.96 |
$2.77M |
13,514 |
| 2026-02-18 |
Davis J. E. |
CEO and President |
RSU 부여 |
73,225 |
$204.96 |
$15.01M |
73,225 |
| 2026-02-18 |
Samad Sam |
Executive Vice President & CFO |
RSU 부여 |
18,303 |
$204.96 |
$3.75M |
18,303 |
| 2026-02-18 |
Deppe Michael J |
SVP, Corp. Controller & CAO |
RSU 부여 |
1,688 |
$204.96 |
$345.97K |
1,688 |
| 2026-02-18 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
RSU 원천징수 |
259 |
$206.99 |
$53.61K |
7,914 |
| 2026-02-18 |
Delaney Mark E |
SVP & Chief Commercial Officer |
RSU 부여 |
7,332 |
$204.96 |
$1.5M |
7,332 |
| 2026-02-13 |
Doherty Catherine T. |
EVP, Regional Businesses |
옵션 행사 (매도) |
26,165 |
$112.17 |
$2.93M |
- |
| 2026-02-10 |
Plewman Patrick |
SVP For Diagnostic Services |
옵션 행사 (매도) |
5,662 |
$121.81 |
$689.66K |
- |
| 2026-01-28 |
Plewman Patrick |
SVP For Diagnostic Services |
RSU 부여 |
48 |
$183.51 |
$8.81K |
15,381 |
| 2026-01-28 |
Carter Robert B |
Director |
소액 거래 |
6 |
$183.51 |
$1.1K |
2,704 |
| 2026-01-28 |
Gregg Vicky B |
Director |
소액 거래 |
67 |
$183.51 |
$12.3K |
17,104 |
| 2026-01-28 |
Samad Sam |
Executive Vice President & CFO |
RSU 부여 |
69 |
$183.51 |
$12.66K |
27,910 |
| 2026-01-28 |
Lassiter Wright Iii |
Director |
소액 거래 |
7 |
$183.51 |
$1.28K |
9,057 |
| 2026-01-28 |
Kuppusamy Karthik |
SVP, Clinical Solutions |
소액 거래 |
16 |
$183.52 |
$2.94K |
10,065 |
| 2026-01-28 |
Delaney Mark E |
SVP & Chief Commercial Officer |
소액 거래 |
15 |
$183.51 |
$2.75K |
8,696 |
| 2025-11-25 |
Gregg Vicky B |
Director |
정보 매도 |
1,250 |
$191.76 |
$239.7K |
17,037 |
| 2025-11-25 |
Davis J. E. |
CEO and President |
옵션 행사 (매도) |
55,093 |
$95.80 |
$5.28M |
- |
| 2025-11-18 |
Delaney Mark E |
SVP & Chief Commercial Officer |
옵션 행사 (매도) |
7,846 |
$144.47 |
$1.13M |
- |
| 2025-11-05 |
Davis J. E. |
CEO and President |
RSU 원천징수 |
7,143 |
$175.57 |
$1.25M |
120,480 |
| 2025-10-23 |
Pfeiffer Gary M |
Director |
임의 매도 |
4,413 |
- |
- |
- |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
